Dupilumab for Grover Disease
Daniel Butler, MD, discusses the use of Dupilumab for treating Grover disease and possible pathophysiology insights based on a recent case series in JAMA Dermatology.
A Multimodal Approach to AK Management
Dr. Neal Bhatia discusses AK prevention strategies, including OTC and in-office treatments, histological AK progression to SCC, SCC incidence, and the need to treat AKs you can and can’t see with multiple modalities. Neal Bhatia, MD, FAAD, is Vice President of the American Academy of Dermatology, and practices at Therapeutics Dermatology, San Diego, Calif. “I’m […]
Ask the experts: What to do about nonmedical switching, formulary exclusions
Brent Moody, MD; Madelaine A. Feldman, MD; and Steven Newmark, JD, MPA, with Lisette Hilton The Dermatology Digest interviewed 3 experts on the topics of nonmedical switching and formulary exclusions, asking them to put these issues into perspective for dermatologists. These experts offered answers to the question of what dermatologists can do to help patients […]